A constant in the history of metabolic and bariatric surgery (MBS) has been the shift in use of various procedures throughout the decades. Differences in their outcomes have become evident through studies which compared them and ultimately guided their utilization [
1]. Now among the safest commonly performed operations, MBS procedures offer an excellent risk-to-benefit ratio for peri-operative (30-day) morbidity and mortality [
- Sugerman HJ
- Starkey JV
- Birkenhauer R
A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters.
Ann Surg. 1987 Jun; 205: 613-624
2]. An interest is now also developing to study the prevalence of long-term effects and how they differ among the modern-day operations. Chronic symptoms after MBS may be extremely complex to describe and assess in the setting of massive weight-loss and overall health improvements. While most patients enjoy long-term benefits after MBS, this outcome is not necessarily universal or guaranteed. The prevalence of chronic abdominal pain (CAP), changes in quality of life (QOL) and their predictive factors merit more clinical scrutiny and scientific evaluation.
- Aminian A
- Brethauer SA
- Kirwan JP
- Kashyap SR
- Burguera B
- Schauer PR
How safe is metabolic/diabetes surgery?.
Diabetes Obes Metab. 2015 Feb; 17: 198-201
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery for Obesity and Related Diseases
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters.Ann Surg. 1987 Jun; 205: 613-624
- How safe is metabolic/diabetes surgery?.Diabetes Obes Metab. 2015 Feb; 17: 198-201
- A prospective longitudinal study of chronic abdominal pain and symptoms after sleeve gastrectomy.Surg Obes Relat Dis. 2021; 17: 2054-2064
- Abdominal pain and symptoms before and after Roux-en-Y gastric bypass.BJS Open. 2019; 3: 317-326
- Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.JAMA Surg. 2022 Aug 1; 157: 656-666
- Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.JAMA. 2018 Jan 16; 319: 255-265
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR; STAMPEDE Investigators. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017 Feb 16;376(7):641-651.
- American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States.Surg Obes Relat Dis. 2020 Apr; 16: 457-463
Accepted: March 12, 2023
Received: February 27, 2023
Publication stageIn Press Journal Pre-Proof
Conflict of interest statement: Dr. Adrian Dan has no conflicts of interest to disclose.
© 2023 Published by Elsevier Inc. on behalf of American Society for Metabolic and Bariatric Surgery.
ScienceDirectAccess this article on ScienceDirect
- Chronic abdominal pain and quality of life after Roux-en-Y gastric bypass and sleeve gastrectomy – a cross-cohort analysis of two prospective longitudinal observational studiesSurgery for Obesity and Related DiseasesOpen Access